Serotype

Last updated
Two serotypes 1a and 1b with antigens 2a and 2b on surface, which are recognized by two distinct antibodies, 3a and 3b, respectively Serotypes - Antibody versus antigen.svg
Two serotypes 1a and 1b with antigens 2a and 2b on surface, which are recognized by two distinct antibodies, 3a and 3b, respectively

A serotype or serovar is a distinct variation within a species of bacteria or virus or among immune cells of different individuals. These microorganisms, viruses, or cells are classified together based on their surface antigens, allowing the epidemiologic classification of organisms to a level below the species. [1] [2] [3] [ clarification needed ] A group of serovars with common antigens is called a serogroup or sometimes serocomplex.[ clarification needed ]

Contents

Serotyping often plays an essential role in determining species and subspecies. The Salmonella genus of bacteria, for example, has been determined to have over 2600 serotypes. Vibrio cholerae , the species of bacteria that causes cholera, has over 200 serotypes, based on cell antigens. Only two of them have been observed to produce the potent enterotoxin that results in cholera: O1 and O139.[ citation needed ]

Serotypes were discovered in hemolytic Streptococci by the American microbiologist Rebecca Lancefield in 1933. [4]

Procedure

Serotyping is the process of determining the serotype of an organism, using prepared antisera that bind to a set of known antigens. Some antisera detect multiple known antigens and are known as polyvalent or broad; others are monovalent. For example, what was once described as HLA-A9 is now subdivided into two more specific serotypes ("split antigens"), HLA-A23 and HLA-A24. As a result, A9 is now known as a "broad" serotype. [5] For organisms with many possible serotypes, first obtaining a polyvalent match can reduce the number of tests required. [6]

The binding between a surface antigen and the antiserum can be experimentally observed in many forms. A number of bacteria species, including Streptococcus pneumoniae , display the Quellung reaction visible under a microscope. [7] Others such as Shigella (and E. coli) and Salmonella are traditionally detected using a slide agglutination test. [6] [8] HLA types are originally determined with the complement fixation test. [9] Newer procedures include the latex fixation test and various other immunoassays.

"Molecular serotyping" refers to methods that replace the antibody-based test with a test based on the nucleic acid sequence therefore actually a kind of genotyping. By analyzing which surface antigen-defining allele(s) are present, these methods can produce faster results. However, their results may not always agree with traditional serotyping, as they can fail to account for factors that affect the expression of antigen-determining genes. [10] [11]

Role in organ transplantation

Agglutination of HLA-A3 positive red blood cells with anti-A3 alloreactive antisera containing Anti-A3 IgM Anti-HLA agglutinated RBC.png
Agglutination of HLA-A3 positive red blood cells with anti-A3 alloreactive antisera containing Anti-A3 IgM

The immune system is capable of discerning a cell as being 'self' or 'non-self' according to that cell's serotype. In humans, that serotype is largely determined by human leukocyte antigen (HLA), the human version of the major histocompatibility complex. Cells determined to be non-self are usually recognized by the immune system as foreign, causing an immune response, such as hemagglutination. Serotypes differ widely between individuals; therefore, if cells from one human (or animal) are introduced into another random human, those cells are often determined to be non-self because they do not match the self-serotype. For this reason, transplants between genetically non-identical humans often induce a problematic immune response in the recipient, leading to transplant rejection. In some situations, this effect can be reduced by serotyping both recipient and potential donors to determine the closest HLA match. [12]

Human leukocyte antigens

Serotypes according to HLA (MHC) locus
HLA Locus# of SerotypesBroad AntigensSplit Antigens
A 25415
B 509
C *121
DR 214
DQ 82
DP *
*DP and many Cw require SSP-PCR for typing.

Bacteria

Most bacteria produce antigenic substances on the outer surface that can be distinguished by serotyping.

The LPS (O) and capsule (K) antigens are themselves important pathogenicity factors. [6] [15]

Some antigens are invariant among a taxonomic group. Presence of these antigens would not be useful for classification lower than the species level, but may inform identification. One example is the enterobacterial common antigen (ECA), universal to all Enterobacterales. [16]

E. coli

E. coli have 187 possible O antigens (6 later removed from list, 3 actually producing no LPS), [17] 53 H antigens, [18] and at least 72 K antigens. [19] Among these three, the O antigen has the best correlation with lineages; as a result, the O antigen is used to define the "serogroup" and is also used to define strains in taxonomy and epidemiology. [17]

Shigella

Shigella are only classfied by their O antigen, as they are non-motile and produce no flagella. Across the four "species", there are 15 + 11 + 20 + 2 = 48 serotypes. [6] Some of these O antigens have eqivalents in E. coli, which also cladistically include Shigella. [20]

Salmonella

The Kauffman–White classification scheme is the basis for naming the manifold serovars of Salmonella. To date, more than 2600 different serotypes have been identified. [21] A Salmonella serotype is determined by the unique combination of reactions of cell surface antigens. For Salmonella, the O and H antigens are used. [22] There are two species of Salmonella: Salmonella bongori and Salmonella enterica . Salmonella enterica can be subdivided into six subspecies. The process to identify the serovar of the bacterium consists of finding the formula of surface antigens which represent the variations of the bacteria. The traditional method for determining the antigen formula is agglutination reactions on slides. The agglutination between the antigen and the antibody is made with a specific antisera, which reacts with the antigen to produce a mass. The antigen O is tested with a bacterial suspension from an agar plate, whereas the antigen H is tested with a bacterial suspension from a broth culture. The scheme classifies the serovar depending on its antigen formula obtained via the agglutination reactions. [8] Additional serotyping methods and alternative subtyping methodologies have been reviewed by Wattiau et al. [23]

Streptococcus

Streptococcus pneumoniae has 93 capsular serotypes. 91 of these serotypes use the Wzy enzyme pathway. The Wzy pathway is used by almost all gram-positive bacteria, by lactococci and streptococci (exopolysacchide), and is also responsible for group 1 and 4 Gram-negative capsules. [24]

Viruses

Other organisms

Many other organisms can be classified using recognition by antibodies.

See also

Related Research Articles

<i>Escherichia coli</i> Enteric, rod-shaped, gram-negative bacterium

Escherichia coli ( ESH-ə-RIK-ee-ə KOH-ly) is a gram-negative, facultative anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is commonly found in the lower intestine of warm-blooded organisms. Most E. coli strains are harmless, but some serotypes such as EPEC, and ETEC are pathogenic and can cause serious food poisoning in their hosts, and are occasionally responsible for food contamination incidents that prompt product recalls. Most strains are part of the normal microbiota of the gut and are harmless or even beneficial to humans (although these strains tend to be less studied than the pathogenic ones). For example, some strains of E. coli benefit their hosts by producing vitamin K2 or by preventing the colonization of the intestine by pathogenic bacteria. These mutually beneficial relationships between E. coli and humans are a type of mutualistic biological relationship — where both the humans and the E. coli are benefitting each other. E. coli is expelled into the environment within fecal matter. The bacterium grows massively in fresh fecal matter under aerobic conditions for three days, but its numbers decline slowly afterwards.

<i>Salmonella</i> Genus of prokaryotes

Salmonella is a genus of rod-shaped (bacillus) gram-negative bacteria of the family Enterobacteriaceae. The two known species of Salmonella are Salmonella enterica and Salmonella bongori. S. enterica is the type species and is further divided into six subspecies that include over 2,600 serotypes. Salmonella was named after Daniel Elmer Salmon (1850–1914), an American veterinary surgeon.

<i>Shigella</i> Genus of bacteria

Shigella is a genus of bacteria that is Gram-negative, facultatively anaerobic, non–spore-forming, nonmotile, rod-shaped, and is genetically closely related to Escherichia. The genus is named after Kiyoshi Shiga, who discovered it in 1897.

<span class="mw-page-title-main">Shiga toxin</span> Family of related toxins

Shiga toxins are a family of related toxins with two major groups, Stx1 and Stx2, expressed by genes considered to be part of the genome of lambdoid prophages. The toxins are named after Kiyoshi Shiga, who first described the bacterial origin of dysentery caused by Shigella dysenteriae. Shiga-like toxin (SLT) is a historical term for similar or identical toxins produced by Escherichia coli. The most common sources for Shiga toxin are the bacteria S. dysenteriae and some serotypes of Escherichia coli (STEC), which includes serotypes O157:H7, and O104:H4.

<i>Salmonella enterica</i> Species of bacterium

Salmonella enterica is a rod-shaped, flagellate, facultative anaerobic, Gram-negative bacterium and a species of the genus Salmonella. It is divided into six subspecies, arizonae (IIIa), diarizonae (IIIb), houtenae (IV), salamae (II), indica (VI), and enterica (I). A number of its serovars are serious human pathogens; many of them are serovars of Salmonella enterica subsp. enterica.

<span class="mw-page-title-main">Bacterial capsule</span> Polysaccharide layer that lies outside the cell envelope in many bacteria

The bacterial capsule is a large structure common to many bacteria. It is a polysaccharide layer that lies outside the cell envelope, and is thus deemed part of the outer envelope of a bacterial cell. It is a well-organized layer, not easily washed off, and it can be the cause of various diseases.

Bacillary dysentery is a type of dysentery, and is a severe form of shigellosis. It is associated with species of bacteria from the family Enterobacteriaceae. The term is usually restricted to Shigella infections.

<i>Shigella flexneri</i> Species of bacterium

Shigella flexneri is a species of Gram-negative bacteria in the genus Shigella that can cause diarrhea in humans. Several different serogroups of Shigella are described; S. flexneri belongs to group B. S. flexneri infections can usually be treated with antibiotics, although some strains have become resistant. Less severe cases are not usually treated because they become more resistant in the future. Shigella are closely related to Escherichia coli, but can be differentiated from E.coli based on pathogenicity, physiology and serology.

<span class="mw-page-title-main">Quellung reaction</span> Reaction in which antibodies bind to bacterial capsule

The quellung reaction, also called the Neufeld reaction, is a biochemical reaction in which antibodies bind to the bacterial capsule of Streptococcus pneumoniae, Klebsiella pneumoniae, Neisseria meningitidis, Bacillus anthracis, Haemophilus influenzae, Escherichia coli, and Salmonella. The antibody reaction allows these species to be visualized under a microscope. If the reaction is positive, the capsule becomes opaque and appears to enlarge.

The AB5 toxins are six-component protein complexes secreted by certain pathogenic bacteria known to cause human diseases such as cholera, dysentery, and hemolytic–uremic syndrome. One component is known as the A subunit, and the remaining five components are B subunits. All of these toxins share a similar structure and mechanism for entering targeted host cells. The B subunit is responsible for binding to receptors to open up a pathway for the A subunit to enter the cell. The A subunit is then able to use its catalytic machinery to take over the host cell's regular functions.

<span class="mw-page-title-main">Leucine-responsive regulatory protein</span>

Leucine responsive protein, or Lrp, is a global regulator protein, meaning that it regulates the biosynthesis of leucine, as well as the other branched-chain amino acids, valine and isoleucine. In bacteria, it is encoded by the lrp gene.

<span class="mw-page-title-main">Hektoen enteric agar</span> Selective and differential agar

Hektoen enteric agar is a selective and differential agar primarily used to recover Salmonella and Shigella from patient specimens. HEA contains indicators of lactose fermentation and hydrogen sulfide production; as well as inhibitors to prevent the growth of Gram-positive bacteria. It is named after the Hektoen Institute in Chicago, where researchers developed the agar.

<span class="mw-page-title-main">Viable but nonculturable</span>

Viable but nonculturable (VBNC) bacteria refers as to bacteria that are in a state of very low metabolic activity and do not divide, but are alive and have the ability to become culturable once resuscitated.

<i>Salmonella enterica <span style="font-style:normal;">subsp.</span> enterica</i> Subspecies of bacterium

Salmonella enterica subsp. enterica is a subspecies of Salmonella enterica, the rod-shaped, flagellated, aerobic, Gram-negative bacterium. Many of the pathogenic serovars of the S. enterica species are in this subspecies, including that responsible for typhoid.

Omptins are a family of bacterial proteases. They are aspartate proteases, which cleave peptides with the use of a water molecule. Found in the outer membrane of gram-negative enterobacteria such as Shigella flexneri, Yersinia pestis, Escherichia coli, and Salmonella enterica. Omptins consist of a widely conserved beta barrel spanning the membrane with 5 extracellular loops. These loops are responsible for the various substrate specificities. These proteases rely upon binding of lipopolysaccharide for activity.

<span class="mw-page-title-main">Cytolethal distending toxin</span>

Cytolethal distending toxins are a class of heterotrimeric toxins produced by certain gram-negative bacteria that display DNase activity. These toxins trigger G2/M cell cycle arrest in specific mammalian cell lines, leading to the enlarged or distended cells for which these toxins are named. Affected cells die by apoptosis.

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

Bacterial effectors are proteins secreted by pathogenic bacteria into the cells of their host, usually using a type 3 secretion system (TTSS/T3SS), a type 4 secretion system (TFSS/T4SS) or a Type VI secretion system (T6SS). Some bacteria inject only a few effectors into their host’s cells while others may inject dozens or even hundreds. Effector proteins may have many different activities, but usually help the pathogen to invade host tissue, suppress its immune system, or otherwise help the pathogen to survive. Effector proteins are usually critical for virulence. For instance, in the causative agent of plague, the loss of the T3SS is sufficient to render the bacteria completely avirulent, even when they are directly introduced into the bloodstream. Gram negative microbes are also suspected to deploy bacterial outer membrane vesicles to translocate effector proteins and virulence factors via a membrane vesicle trafficking secretory pathway, in order to modify their environment or attack/invade target cells, for example, at the host-pathogen interface.

<span class="mw-page-title-main">Edward Thomas Ryan</span> American microbiologist

Edward Thomas Ryan is an American microbiologist, immunologist, and physician at Harvard University and Massachusetts General Hospital. Ryan served as president of the American Society of Tropical Medicine and Hygiene from 2009 to 2010. Ryan is Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, Professor of Medicine at Harvard Medical School, and Director of Global Infectious Diseases at the Massachusetts General Hospital. Ryan's research and clinical focus has been on infectious diseases associated with residing in, immigrating from, or traveling through resource-limited areas. Ryan is a Fellow of the American Society of Microbiology, the American Society of Tropical Medicine and Hygiene, the American College of Physicians, and the Infectious Diseases Society of America.

<span class="mw-page-title-main">MCR-1</span>

The mobilized colistin resistance (mcr) gene confers plasmid-mediated resistance to colistin, one of a number of last-resort antibiotics for treating Gram-negative infections. mcr-1, the original variant, is capable of horizontal transfer between different strains of a bacterial species. After discovery in November 2015 in E. coli from a pig in China it has been found in Escherichia coli, Salmonella enterica, Klebsiella pneumoniae, Enterobacter aerogenes, and Enterobacter cloacae. As of 2017, it has been detected in more than 30 countries on 5 continents in less than a year.

References

  1. Baron EJ (1996). Baron S; et al. (eds.). Classification. In: Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN   978-0-9631172-1-2. (via NCBI Bookshelf).
  2. Ryan KJ, Ray CG, Sherris JC, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN   978-0-8385-8529-0.
  3. "Serovar". The American Heritage Medical Dictionary. Houghton Mifflin Company. 2007.
  4. Lancefield RC (March 1933). "A Serological Differentiation of Human and Other Groups of Hemolytic Streptococci". The Journal of Experimental Medicine. 57 (4): 571–95. doi:10.1084/jem.57.4.571. PMC   2132252 . PMID   19870148.
  5. Fussell H, Thomas M, Street J, Darke C (1996). "HLA-A9 antibodies and epitopes". Tissue Antigens. 47 (4): 307–12. doi:10.1111/j.1399-0039.1996.tb02558.x. PMID   8773320.
  6. 1 2 3 4 "Laboratory Protocol: "Serotyping of Shigella spp."" (PDF). WHO Global Foodborne Infections Network.
  7. Habib, M; Porter, BD; Satzke, C (24 February 2014). "Capsular serotyping of Streptococcus pneumoniae using the Quellung reaction". Journal of Visualized Experiments : JoVE (84): e51208. doi: 10.3791/51208 . PMC   4131683 . PMID   24637727.
  8. 1 2 Danan C, Fremy S, Moury F, Bohnert ML, Brisabois A (2009). "Determining the serotype of isolated Salmonella strains in the veterinary sector using the rapid slide agglutination test". J. Reference. 2: 13–8.
  9. Kissmeyer-Nielsen, F. (1980). The Serology of HLA-A, -B, and -C. Clinical Immunobiology. Vol. 4. pp. 99–111. doi:10.1016/B978-0-12-070004-2.50012-8. ISBN   9780120700042.
  10. Luo Y, Huang C, Ye J, Octavia S, Wang H, Dunbar SA, et al. (2020-09-07). "Comparison of xMAP Salmonella Serotyping Assay With Traditional Serotyping and Discordance Resolution by Whole Genome Sequencing". Frontiers in Cellular and Infection Microbiology. 10: 452. doi: 10.3389/fcimb.2020.00452 . PMC   7504902 . PMID   33014887. However, similar to all molecular assays, genotyping assay does not necessary correlate with phenotypic assay as genes may not be expressed.
  11. Lacher, DW; Gangiredla, J; Jackson, SA; Elkins, CA; Feng, PC (August 2014). "Novel microarray design for molecular serotyping of shiga toxin- producing Escherichia coli strains isolated from fresh produce". Applied and Environmental Microbiology. 80 (15): 4677–4682. Bibcode:2014ApEnM..80.4677L. doi: 10.1128/AEM.01049-14 . PMC   4148803 . PMID   24837388. Furthermore, the array identified the H types of 97% of the produce STEC strains compared to 65% by serology, including six strains that were mistyped by serology.
  12. Frohn C, Fricke L, Puchta JC, Kirchner H (February 2001). "The effect of HLA-C matching on acute renal transplant rejection". Nephrology, Dialysis, Transplantation. 16 (2): 355–60. doi:10.1093/ndt/16.2.355. PMID   11158412.
  13. Wang, L; Wang, Q; Reeves, PR (2010). "The variation of O antigens in gram-negative bacteria". Sub-cellular Biochemistry. 53: 123–52. doi:10.1007/978-90-481-9078-2_6. ISBN   978-90-481-9077-5. PMID   20593265.
  14. Ratiner, YA; Salmenlinna, S; Eklund, M; Keskimäki, M; Siitonen, A (March 2003). "Serology and genetics of the flagellar antigen of Escherichia coli O157:H7a,7c". Journal of Clinical Microbiology. 41 (3): 1033–40. doi:10.1128/JCM.41.3.1033-1040.2003. PMC   150270 . PMID   12624026.
  15. 1 2 Arredondo-Alonso, Sergio; Blundell-Hunter, George; Fu, Zuyi; Gladstone, Rebecca A.; Fillol-Salom, Alfred; Loraine, Jessica; Cloutman-Green, Elaine; Johnsen, Pål J.; Samuelsen, Ørjan; Pöntinen, Anna K.; Cléon, François; Chavez-Bueno, Susana; De la Cruz, Miguel A.; Ares, Miguel A.; Vongsouvath, Manivanh; Chmielarczyk, Agnieszka; Horner, Carolyne; Klein, Nigel; McNally, Alan; Reis, Joice N.; Penadés, José R.; Thomson, Nicholas R.; Corander, Jukka; Taylor, Peter W.; McCarthy, Alex J. (15 June 2023). "Evolutionary and functional history of the Escherichia coli K1 capsule". Nature Communications. 14 (1): 3294. Bibcode:2023NatCo..14.3294A. doi: 10.1038/s41467-023-39052-w . PMC   10272209 . PMID   37322051.
  16. Rai, AK; Mitchell, AM (11 August 2020). "Enterobacterial Common Antigen: Synthesis and Function of an Enigmatic Molecule". mBio. 11 (4). doi: 10.1128/mBio.01914-20 . PMC   7439462 . PMID   32788387.
  17. 1 2 Liu, Bin; Furevi, Axel; Perepelov, Andrei V; Guo, Xi; Cao, Hengchun; Wang, Quan; Reeves, Peter R; Knirel, Yuriy A; Wang, Lei; Widmalm, Göran (24 November 2020). "Structure and genetics of Escherichia coli O antigens". FEMS Microbiology Reviews. 44 (6): 655–683. doi: 10.1093/femsre/fuz028 . PMC   7685785 . PMID   31778182.
  18. Wang L; Rothemund D; Reeves PR (May 2003). "Species-Wide Variation in the Escherichia coli Flagellin (H-Antigen) Gene". Journal of Bacteriology. 185 (9): 2396–2943. doi:10.1128/JB.185.9.2936-2943.2003. PMC   154406 . PMID   12700273.
  19. Kunduru, BR; Nair, SA; Rathinavelan, T (4 January 2016). "EK3D: an E. coli K antigen 3-dimensional structure database". Nucleic Acids Research. 44 (D1): D675-81. doi: 10.1093/nar/gkv1313 . PMC   4702918 . PMID   26615200.
  20. Liu, Bin; Knirel, Yuriy A.; Feng, Lu; Perepelov, Andrei V.; Senchenkova, Sof'ya N.; Wang, Quan; Reeves, Peter R.; Wang, Lei (July 2008). "Structure and genetics of Shigella O antigens". FEMS Microbiology Reviews. 32 (4): 627–653. doi: 10.1111/j.1574-6976.2008.00114.x . PMID   18422615.
  21. Gal-Mor O, Boyle EC, Grassl GA (2014). "Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ". Frontiers in Microbiology. 5: 391. doi: 10.3389/fmicb.2014.00391 . PMC   4120697 . PMID   25136336.
  22. "Serotypes and the Importance of Serotyping Salmonella". CDC. Retrieved 16 October 2014.
  23. Wattiau P, Boland C, Bertrand S (November 2011). "Methodologies for Salmonella enterica subsp. enterica subtyping: gold standards and alternatives". Applied and Environmental Microbiology. 77 (22): 7877–85. Bibcode:2011ApEnM..77.7877W. doi:10.1128/AEM.05527-11. PMC   3209009 . PMID   21856826.
  24. Yother, J (2011). "Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation". Annual Review of Microbiology. 65: 563–81. doi:10.1146/annurev.micro.62.081307.162944. PMID   21721938.
  25. Chulay, JD; Haynes, JD; Diggs, CL (1985). "Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth". Bulletin of the World Health Organization. 63 (2): 317–23. PMC   2536403 . PMID   3893775.
  26. Cowan, Graeme J. M.; Creasey, Alison M.; Dhanasarnsombut, Kelwalin; Thomas, Alan W.; Remarque, Edmond J.; Cavanagh, David R. (26 October 2011). "A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response". PLOS ONE. 6 (10): e26616. Bibcode:2011PLoSO...626616C. doi: 10.1371/journal.pone.0026616 . PMID   22073118.
  27. Shobab, Leila; Pleyer, Uwe; Johnsen, Joerdis; Metzner, Sylvia; James, Erick R.; Torun, N.; Fay, Michael P.; Liesenfeld, Oliver; Grigg, Michael E. (1 November 2013). "Toxoplasma Serotype Is Associated With Development of Ocular Toxoplasmosis". The Journal of Infectious Diseases. 208 (9): 1520–1528. doi: 10.1093/infdis/jit313 . PMC   3789564 . PMID   23878321.
  28. Balouz, Virginia; Bracco, Leonel; Ricci, Alejandro D.; Romer, Guadalupe; Agüero, Fernán; Buscaglia, Carlos A. (March 2021). "Serological Approaches for Trypanosoma cruzi Strain Typing". Trends in Parasitology. 37 (3): 214–225. doi:10.1016/j.pt.2020.12.002. PMC   8900812 . PMID   33436314.